KP Tissue Inc. saw a modest gain this week amid recent financial announcements.
KP Tissue Inc. (KPT.TO) experienced a slight increase in stock price this week, closing up 0.16% on Friday. This follows recent financial results that have captured investor attention. As the company continues to navigate the consumer staples sector, let's delve into the latest developments affecting KP Tissue's stock performance.
Advertisement
KP Tissue Inc
KPT.TO
KPT.TO
KP Tissue Inc
WealthAwesomeMarket cap
$127.81M
P/E
14.5x
Div. yield
5.71%
Div. / share
$0.72
52W high
$13.61
52W low
$8.68
1W change
+0.08%
Beta
0.40
Analyst Price Targets
Based on analyst covering KPT
Wall Street analysts forecast KPT stock price to rise 3.2% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$13.13
+3.2% Upside
Current Price
C$12.72
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on KPT's historical volatility
30-Day Vol
10.6%
Annualized
90-Day Vol
15.1%
Annualized
Trend (90d)
+8.7%
Annualized drift
90d Mean
C$13.12
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$12.85 | C$12.39 โ C$13.33 |
| 60 trading days | C$12.99 | C$12.33 โ C$13.67 |
| 90 trading days | C$13.12 | C$12.32 โ C$13.98 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: While KP Tissue has shown resilience with a year-to-date gain of 26.42%, investors should consider the company's recent financial results and upcoming announcements as key indicators of future performance.
KP Tissue Inc. Reports Revenue of $544.6 Million in Q1 2026
The revenue figure, while slightly down from the previous year, is supported by a notable increase in adjusted EBITDA, highlighting profitability amidst a challenging environment.
Bull case
KP Tissue's financial performance in 2025 was strong, with revenue increasing by 7.5% and a significant rise in adjusted EBITDA. This shows that the company has a solid operational foundation. The declared quarterly dividend of $0.21 per share also demonstrates the company's commitment to returning value to shareholders.
Bear case
Despite the positive outlook, the slight revenue decrease in Q1 2026 raises concerns about sustainable growth. Additionally, a profit margin of 0.0% indicates that the company may face challenges in improving profitability.
Recent Price Action
Advertisement
KP Tissue Inc. closed at C$12.84 on Friday, marking a 1D gain of 0.16% and a weekly increase of 0.94%. Over the past month, the stock has seen a decline of 2.27%, yet it remains up 26.42% year-to-date.
Company News and Financial Performance
Recently, KP Tissue released its financial results for Q1 2026, reporting revenue of $544.6 million, which is a slight decline of 0.3% from the prior year. However, adjusted EBITDA increased by 14.6%, suggesting that the company is managing its operational efficiency well despite the revenue dip. The company also declared a quarterly dividend of $0.21 per share, reflecting its ongoing commitment to shareholder returns.
Technical Picture
KP Tissue's stock is currently trading close to its 50-day moving average of C$12.86, with a slight deviation of -0.2%. The 200-day moving average stands at C$11.07, indicating a positive trend of +16.0% compared to the current price. The stock's 52-week range has been between C$8.40 and C$13.61, with the current price representing 85% of this range. KP Tissue has a beta of 0.40, suggesting lower volatility compared to the market, and its latest trading volume was 11,811 shares, which is 0.49 times the 20-day average volume of 15,066 shares.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
